Clinical Trial Update: A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HT-101 and HT-102 in Chronic Hepatitis B showing status as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HT-101
• HT-102

Snippet

Sponsor: Suzhou HepaThera Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: ACTIVE_NOT_RECRUITING